Vol 3: Glucagon-like peptide-1: effect on pro-atrial natriuretic peptide in healthy males.Reportar como inadecuado



 Vol 3: Glucagon-like peptide-1: effect on pro-atrial natriuretic peptide in healthy males.


Vol 3: Glucagon-like peptide-1: effect on pro-atrial natriuretic peptide in healthy males. - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Descargar gratis o leer online en formato PDF el libro: Vol 3: Glucagon-like peptide-1: effect on pro-atrial natriuretic peptide in healthy males.
This article is from Endocrine Connections, volume 3.AbstractThe antihypertensive actions of glucagon-like peptide-1 (GLP1) receptor agonists have been linked to the release of atrial natriuretic peptide (ANP) in mice. Whether a GLP1–ANP axis exists in humans is unknown. In this study, we examined 12 healthy young males in a randomized, controlled, double-blinded, single-day, cross-over study to evaluate the effects of a 2-h native GLP1 infusion. Plasma proANP concentrations were measured by an automated mid-region-directed proANP immunoassay and N-terminal pro B-type natriuretic peptide (BNP) on Roche Modular E170. Urine was collected for measurements of sodium excretion. Although GLP1 infusion increased the urinary sodium excretion markedly, there were no significant changes in either proANP or proBNP concentrations. When GLP1 infusion was stopped, sodium excretion declined rapidly. As proANP concentration reflects ANP secretion, our data could not confirm the existence of a GLP1–ANP axis in humans. Especially, the natriuretic effects of GLP1 seem unlikely to be mediated exclusively via ANP.



Autor: Skov, Jeppe; Holst, Jens Juul; G?tze, Jens Peter; Fr?kiaer, J?rgen; Christiansen, Jens Sandahl

Fuente: https://archive.org/







Documentos relacionados